drugset / Trial / NCT02577458
Study of the Combination of CM082 With Everolimus in Patients With mRCC
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase I Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CM082 in Combination with Everolimus in Chinese Patients With Advanced Renal Cell Carcinoma.
Timeline
- Start
- 2015-09
- Primary completion
- 2018-03
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM082 | Unknown | — | Oral |
| Background | Everolimus | Small molecule | — | Oral |